Skip to main content
TipRanks
Go Ultimate75% OFF

Arctic Bioscience AS (9TD) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Arctic Bioscience AS has a market cap or net worth of EUR 6.85M. The enterprise value is EUR 167.56M.

Market Cap
EUR 6.85M
Enterprise Value
EUR 167.56M

Share Statistics

Arctic Bioscience AS has 26,956,257 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
26,956,257
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Arctic Bioscience AS’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -19.62%.

Return on Equity (ROE)
-0.23
Return on Assets (ROA)
-0.17
Return on Invested Capital (ROIC)
-19.62%
Return on Capital Employed (ROCE)
-0.23
Revenue Per Employee
2.29M
Profits Per Employee
-2.52M
Employee Count
19
Asset Turnover
0.16
Inventory Turnover
1.09

Valuation Ratios

The current PE Ratio of Arctic Bioscience AS is -1.73. Arctic Bioscience AS’s PEG ratio is -3.30.

PE Ratio
-1.73
PS Ratio
1.97
PB Ratio
0.39
Price to FCF
-0.91
Price to Operating Cash Flow
-1.83
PEG Ratio
-3.30

Income Statement

In the last 12 months, Arctic Bioscience AS had revenue of 43.48M and earned -47.93M in profits. Earnings per share was -1.88.

Revenue
43.48M
Gross Profit
11.89M
Operating Income
-47.79M
Pretax Income
-47.93M
Net Income
-47.93M
EBITDA
-39.63M
Earnings Per Share (EPS)
-1.88

Cash Flow

In the last 12 months, operating cash flow was -45.36M and capital expenditures -50.81M, giving a free cash flow of -96.17M billion.

Operating Cash Flow
-45.36M
Free Cash Flow
-96.17M
Free Cash Flow per Share
-3.78

Dividends & Yields

Arctic Bioscience AS pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-109.83%
Earnings Yield
-57.80%

Stock Price Statistics

Beta
-0.73
52-Week Price Change
-34.67%
50-Day Moving Average
0.17
200-Day Moving Average
0.21
Relative Strength Index (RSI)
51.10
Average Volume (3m)
―

Important Dates

Arctic Bioscience AS upcoming earnings date is May 13, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 27, 2026
Next Earnings Date
May 13, 2027
Ex-Dividend Date
―

Financial Position

Arctic Bioscience AS as a current ratio of 0.86, with Debt / Equity ratio of 15.59%

Current Ratio
0.86
Quick Ratio
0.43
Debt to Market Cap
0.67
Net Debt to EBITDA
-0.77
Interest Coverage Ratio
-15.18

Taxes

In the past 12 months, Arctic Bioscience AS has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Arctic Bioscience AS EV to EBITDA ratio is -2.63, with an EV/FCF ratio of -1.23.

EV to Sales
2.66
EV to EBITDA
-2.63
EV to Free Cash Flow
-1.23
EV to Operating Cash Flow
-2.61

Balance Sheet

Arctic Bioscience AS has EUR 2.16M in cash and marketable securities with EUR 32.86M in debt, giving a net cash position of -EUR 30.70M billion.

Cash & Marketable Securities
EUR 2.16M
Total Debt
EUR 32.86M
Net Cash
-EUR 30.70M
Net Cash Per Share
-EUR 1.14
Tangible Book Value Per Share
EUR 8.15

Margins

Gross margin is 28.84%, with operating margin of -107.62%, and net profit margin of -107.95%.

Gross Margin
28.84%
Operating Margin
-107.62%
Pretax Margin
-107.95%
Net Profit Margin
-107.95%
EBITDA Margin
-101.12%
EBIT Margin
-107.62%

Analyst Forecast

The average price target for Arctic Bioscience AS is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
7.41%
EPS Growth Forecast
9.32%